Patents Represented by Attorney, Agent or Law Firm Bolesh J. Skutnik
  • Patent number: 6830580
    Abstract: The present invention provides a system and method for improved biostimulative effect through the use of single mode fibers to transport coherent light to a treatment site. Single mode fibers or groups/bundles of single mode waveguides for the relevant irradiation wavelength are used for radiation transport. Selective leakage of the radiation from this delivery system is achieved at the desired application sites of the biostimulation by suitable means, one being evanescent wave decouplers. The result is a low intensity exposure of coherent light to tissue or organic material that is more effective than conventional biostimulative procedures. Delivery systems based on such waveguides can cover large areas due to the low transmission losses of the waveguide. The waveguide can be inserted into hydrocultures or earth to provide radiation and thus biostimulation of seeds and cuttings in situ. Coherent radiation can also improve the health, healing and fertility of animals.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: December 14, 2004
    Assignee: CeramOptec Industries, Inc.
    Inventor: Wolfgang Neuberger
  • Patent number: 6821289
    Abstract: A safer, improved method of photodynamic therapy is provided for treating diseased, hyperproliferative tissue, including cancer, psoriasis, and arthritis, using multiple, sequential administrations of a photosensitizer (PS) prior to irradiation. Preferred photosensitizers are characterized by being retained in the diseased tissue for a longer time than in normal tissue. The interval between administrations is chosen to be of sufficient duration to allow the PS content of normal tissues to drop to a basal or negligible level before the next administration and before irradiation. At that time, the PS content of the diseased tissue is still high, not less than half of the initial content after the last PS administration. In this way, PDT with better selectivity for the diseased tissue is achieved. With sequential PS administrations, the PS burden on normal tissue can be kept low, so that side effects can be reduced, for example damage of the skin by sunlight or bright indoors artificial lighting.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: November 23, 2004
    Assignee: CeramOptec Industries, Inc.
    Inventors: Hans-Peter Bode, Volker Albrecht
  • Patent number: 6810184
    Abstract: The present invention provides improved diffusion tips for optical fibers and methods of making the same. Nanoporous silica clad optical fibers are used to make fibers having integrally formed diffusion tips and diffusion tips that can be fused to other fibers. The disclosed diffusers can be fabricated to be cylindrical with light diffusing along its length, spherical with light radiating outwardly in a spherical pattern, or custom shaped to illuminate irregular surfaces or volumes. Gradient and step index properties can also be achieved. Several fabrication methods to achieve the desired effects are described. The problems in the prior art methods associated with epoxy, such as curing, bond strength, embrittlement, power handling limitations, and refractive index matching are avoided.
    Type: Grant
    Filed: January 9, 2002
    Date of Patent: October 26, 2004
    Assignee: Ceram Optec Industries Inc.
    Inventor: Bolesh J. Skutnik
  • Patent number: 6806284
    Abstract: The present invention provides a drug delivery system wherein a “parachute” structure is coupled to a therapeutic compound. The “parachute” structure comprises hydrophilic branched molecules with a defined action diameter. The complex (a parachute structure coupled with a therapeutic compound) is either fixed at a cell membrane or delivered to a defined distance from the membrane within the cell. The membrane-anchoring/localizing effect of the parachute is achieved by hydrophilic structures linked with a branching unit of desired therapeutic compounds. Furthermore, the parachute structures can be connected by a spacer (e.g. &bgr;-amino acids, &ggr;-amino butyric acid, or poly-amino acids) instead of directly binding to the therapeutic compound, so that the therapeutic compounds can be localized within the cells at a defined distance from the cell membrane. A spacer containing a breaking point can determine the time span, during which the drug exhibits its therapeutic activity.
    Type: Grant
    Filed: June 22, 2000
    Date of Patent: October 19, 2004
    Assignee: Ceram Optec Industries, Inc.
    Inventor: Jörg G. Moser
  • Patent number: 6777402
    Abstract: High purity pharmaceutical-grade water-soluble porphyrin derivatives given by formula 1 or 2 in the specification, and new methods to prepare and use such porphyrin derivatives are disclosed. A preferred method comprises the steps of one- or two-step direct acidic alcoholysis of biological raw material producing a crystalline alkyl pheophorbide, conversion of the obtained alkyl pheophorbide into an acidic porphyrin, and reaction of the acidic porphyrin in water or in an aqueous organic solution with a hydrophilic organic amine. Another preferred method comprises reaction of acidic porphyrins prepared in water or in aqueous organic solution with a hydrophilic organic amine. Another preferred method comprises the additional step of purification of the resultant water-soluble porphyrin derivative by reversed phase chromatography using volatile solvents.
    Type: Grant
    Filed: May 20, 2002
    Date of Patent: August 17, 2004
    Assignee: CeramOptec Industries, Inc.
    Inventors: Nikolay E. Nifantiev, Dmitri V. Yashunsky
  • Patent number: 6758844
    Abstract: A system and method is disclosed for improved treatment of oral tissues using 980 nm laser radiation and a handpiece with means for concurrently delivering the laser radiation and a liquid/gas spray onto the treatment area to improve the treatment effects. Unwanted heating and carbonization of surrounding tissues is reduced. The liquid/gas spray may be mixed inside the handpiece or in a separate device. The combination of cooling sprays with radiation wavelengths having high absorption in water has previously been avoided due to the thought that energy absorption by the cooling fluid would render the energy delivered to the tissue uncontrollable and of minimal benefit. Preferably, pulsed laser light provides a localized energy deposition and heating to avoid unwanted heating of underlying tissue. The liquid spray flushes away tissue debris in addition to cooling the treated tissue.
    Type: Grant
    Filed: January 24, 2002
    Date of Patent: July 6, 2004
    Assignee: CeramOptec Industries, Inc.
    Inventor: Wolfgang Neuberger
  • Patent number: 6724963
    Abstract: The present invention provides for an apparatus and method to manufacture optical fiber in a way that produces controlled and patterned diffusion of optical radiation along its length. The novelty of the described invention is that the patterns of diffusion are produced at the time the optical fiber is manufactured. The “in-line” manufacturing method avoids the need for post-production treatment of the fiber, which makes the process highly efficient and economical. Light diffusing optical fibers of significant length can be produced. Several manufacturing configurations to achieve the desired effects and their inclusion in the fiber production process are described. The processes can be configured to process optical fibers constructed from a wide variety of known glass, polymeric or other materials. The partially diffusing optical fibers of this invention have applications ranging from illuminated fabrics and toys and to lighting systems and medical instruments.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: April 20, 2004
    Assignee: CeramOptec Industries, Inc.
    Inventor: Wolfgang Neuberger
  • Patent number: 6685927
    Abstract: A device and method is disclosed for permanent or semi-permanent removal of hair through the activation of microparticles introduced into hair follicles. Microparticles are incorporated into a composition that is topically applied to the skin. These microparticles containing or consisting of chromophores or chemically activated molecules are of a variety of shapes and sizes. Microparticles are within a size range of 1 micron to 70 microns, and preferably between 10 and 50 microns. Microparticles of this size and variety of shapes enter hair follicles on all areas of the skin without entering other areas of the skin, such as the stratum corneum or sweat gland channels. Treatment of the skin with electromagnetic radiation, ultrasonic radiation or chemical means activates the chromophore or chemically activated compounds, thus destroying the hair follicle without damaging other areas of the skin.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: February 3, 2004
    Assignee: CeramOptec Industries, Inc.
    Inventors: Chryslain Sumian, Wolfgang Neuberger, Serge Mordon
  • Patent number: 6664228
    Abstract: A drug delivery system and methods are provided wherein a therapeutic/diagnostic agent or a component of the immune system is directed to particular cells in a selected organ or a specific site. Such a system can be formed by a photoselective compound generally described as V-M-P-C. V is a vector component suitable to target particular cells in a selected organ or site, where the type of the cell or antigen does not have to be specific to the desired treatment site. M is a marker component that is capable of being targeted by a therapeutic/diagnostic agent or a component of the immune system. P is a photocleavable or photosensitive bond, and C is a cap component rendering M ineffective. C is connected to M by the photocleavable or photosensitive bond. The photoselective compound is administered and marks targets of a certain kind of cell or a specific site.
    Type: Grant
    Filed: August 10, 2000
    Date of Patent: December 16, 2003
    Assignee: CeramOptec Industries, Inc.
    Inventors: Jörg G Moser, Wolfgang Neuberger
  • Patent number: 6660000
    Abstract: A photonic scanning and delivery system capable of controllable transmission of light energy to an irregularly shaped treatment area are disclosed. The desired uniformity (controllability) of light energy application is ensured by a tracking device, which monitors the position of the radiation applicator and thereby prevents over- or under-radiation. The system employs a light energy delivery hand-piece. By these means, structures in the lower dermis are irradiated. Because of the large size of the treatment area, damage to surface tissue is avoided. The hand-piece can operate while in contact with the treatment surface. Treatment surfaces include non-medical work sites. Alternatively, the hand-piece can operate in a non-contact mode. The system can also be used in non-medical applications such as UV curing.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: December 9, 2003
    Assignee: CeramOptec Industries, Inc.
    Inventors: Wolfgang Neuberger, Michael Quade
  • Patent number: 6650663
    Abstract: A diode pumped fiber laser is described that utilizes highly erbium-doped fluoride glass to produce 1 W and higher outputs at about 3 &mgr;m. High dopant concentrations in fluoride glass make it possible to efficiently pump the laser around 975 nm which in turn leads to higher slope efficiencies for the laser. Furthermore, by using this pumping wavelength, saturation of laser output due to bleaching of the ground state is overcome. The fluoride glass composition is a modified version of the standard ZBLAN composition. This altered composition achieves high glass quality, enables fiber drawing, and avoids the problem of crystallization.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: November 18, 2003
    Assignee: CeramOptec Industries, Inc.
    Inventors: Andreas Diening, Thomas Sandrock
  • Patent number: 6642214
    Abstract: A cyclodextrin oligomer comprising two cyclodextrins connected through a spacer at the secondary side, characterized in that said spacer comprises the unit B which is a rigid and preferably hydrophilic structural element.
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: November 4, 2003
    Assignee: CeramOptec Industries, Inc.
    Inventor: Joerg G Moser
  • Patent number: 6602988
    Abstract: A rigidly spaced, cyclodextrin dimers having a preselected breaking point within the spacer sequence so as to controllably release the active pharmaceutically active substance only after it reaches the desired treatment site is described. These preselected breaking points are stable in blood but are cleavable within cells. In preferred embodiments, the cyclodextrin-pharmaceutically active substance complex is targeted to specific sites via incorporation of specific antibodies for the targeted sites, typically by complexing a biotin-avidin system to specific antibodies which thereby targets the complex to a specific site. Once at the site as the complex is taken up into the cell the preselected break point is cleaved and the encapsulated pharmaceutically active substance becomes available for action within the targeted cell.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: August 5, 2003
    Assignee: CeramOptec Industries, Inc.
    Inventors: Jörg G. Moser, Ralph Hoffmann
  • Patent number: 6574401
    Abstract: The present invention describes a multi-component handpiece that is both economical and practical for surgical laser treatment. A disposable optical fiber is inserted into a reusable handpiece. The distal end of the optical fiber is protected by a micro-walled protective tube to prevent the disposable fiber from chipping before and during insertion into the handpiece. Once the optical fiber is protected, it is inserted into the handpiece by threading the optical fiber through the cap, body, and cannula of the handpiece until the fiber extends slightly beyond the distal end of the needle. The micro-walled protective tube is removed from the end of the optical fiber, the optical fiber is positioned, and the cap is tightened. The cap and body of the handpiece cooperate to produce a tight friction fit that prevents longitudinal movement of the optical fiber during laser therapy.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: June 3, 2003
    Assignee: CeramOptec Industries, Inc.
    Inventors: Wolfgang Neuberger, Brian Foley
  • Patent number: 6561808
    Abstract: A method and material for self-cleaning of the teeth and mouth using a source of light in the visible range in conjunction with a photosensitive oral hygiene composition possessing a broad absorption spectrum in the visible range. The invention selectively eliminates harmful bacteria by use of a photosensitive agent and a light source. The present invention involves the use of a light-providing dental device to activate a photosensitive agent and destroy harmful bacteria in the oral cavity. It prevents or deters oral diseases, inflammations, and infections.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: May 13, 2003
    Assignee: CeramOptec Industries, Inc.
    Inventor: Wolfgang Neuberger
  • Patent number: 6562295
    Abstract: A novel approach to fight bacterial growth on and attachment to medical devices/implants is described. This approach reduces the necessity of the painful and complicated replacement of the medical devices that frequently need to remain in the body for periods of time longer than is recommended using a traditionally sterilized device. Several methods are described to kill bacteria that have attached to the surface of medical devices. Long term use is then possible with those medical devices. Furthermore a medical device is described under this method that has a photosensitizing compound affixed to or near the device surface with means to periodically activate the compound by suitable illumination.
    Type: Grant
    Filed: June 30, 1999
    Date of Patent: May 13, 2003
    Assignee: CeramOptec Industries, Inc.
    Inventor: Wolfgang Neuberger
  • Patent number: 6527764
    Abstract: The present invention provides a device and method for a laser treatment that couples surgical or activating laser power with a biomodulating power to enhance proper tissue healing and regeneration after treatment. This treatment is achieved using an optical fiber system delivering laser power from two separate laser sources. One source provides laser energy at a power level and density suitable for the surgical or activation action desired. The second source produces laser power at a wavelength suitable for producing biomodulating effects in the treated tissue. Biomodulation treatment of the tissue promotes cellular healing and regeneration and ensures that proper healing occurs. In addition, the present invention describes a method by which the device is used for treatment. The surgical or activating laser energy is applied to a site as the device is passed over the treatment area.
    Type: Grant
    Filed: December 2, 1999
    Date of Patent: March 4, 2003
    Assignee: CeramOptec Industries, Inc.
    Inventors: Wolfgang Neuberger, Stefan Spaniol
  • Patent number: 6503268
    Abstract: Laser systems medical or cosmetic applications, comprising diode lasers or diode lasers with other solid state lasers which can deliver up to 30 cw or more, and which generally operate at more than wavelength within the range of 1000 to 1300 nm are presented. Individual emitter or emitter groups within the diode laser system can be powered independently. These laser systems provide maximum penetration depths for procedures such as Laser-induced Interstitial Tumor Therapy, alone or in conjunction with other therapies such as PhotoDynamic Therapy, chemotherapy, or radiation therapy. Where beneficial for the procedure, the operating wavelength of the system can be changed without interruption. In some variants, active tissue cooling at the distal end of the delivery fibers is incorporated as well as individual feedback loops to control and stabilize the temperature induced in the tissue.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: January 7, 2003
    Assignee: CeramOptec Industries, Inc.
    Inventors: Wolfgang Neuberger, Hans-Joachim Schwarzmaier
  • Patent number: 6494878
    Abstract: A system and method is provided to accurately treat sites on an eye's retina employing computer based image generation, processing and central control means in conjunction with diode laser sources and optical fibers. The system and method accurately determine geometry of a treatment zone of a specific eye's fundus and adjust a treatment beam to irradiate the treatment zone with minimal coverage of adjacent well tissue. The treatment zone or zone is accurately determined with digital processing of angiographic data and slit lamp image data. This information is integrated with information on the treatment beam characteristics to better match treatment beam coverage with minimal overlap with healthy areas of the fundus. Additionally preferred embodiments also have the ability to automatically track eye movement and switch the beam source depending on eye movement, adjusting the beam spot area in real time.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: December 17, 2002
    Assignee: CeramOptec Industries, Inc.
    Inventors: Dirk Pawlowski, Wolfgang Neuberger
  • Patent number: 6485562
    Abstract: The invention relates to the field of producing material that has a low absorbance in the 5 to 15 micron wavelength range. The process is particularly useful for producing single crystals of silver halides for use in manufacturing fiber optic light guides with low optic loss in the medium IR range. This invention covers a totality of process steps and a sequential order in which they are carried out. The process of synthesizing this low IR absorbing material requires careful preparation of raw materials into suitable starting materials, followed by mixing specific ratios of the starting materials. A specific melting process then further purifies the mix. Once this initial purification process is completed, a specialized second purification process is performed on the material from the first process. This second purification process yields the proper material for crystallization via the Stockbarger-Bridgeman method.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: November 26, 2002
    Assignee: CeramOptec Industries, Inc.
    Inventors: Igor S. Lisitsky, Valeri F. Golovanov, Galina V. Poliakova